AAOI
Applied Optoelectronics, Inc.
AAOI lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
MYSE
Myseum Inc.
There isn't enough reported data to score MYSE yet.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
MYSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
MYSE's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
MYSE PE Valuation
MYSE has no meaningful PE right now: it lost money over the past year.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AAOI to return to profit, with revenue growing. However, they disagree widely on these estimates.
MYSE Forward outlook
There aren't enough analyst estimates for MYSE to show an outlook.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI has the stronger earnings trend. Trailing diluted EPS is down 112% for AAOI versus MYSE down 147%.
MYSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2021 | -$2.65 | -$1.88 |
| Q2 2021 | -$1.69 | -$0.94 |
| Q1 2021 | -$1.34 | +$1.66 |
| Q4 2020 | -$0.73 | +$4.51 |
MYSE lost $1.25 per share over the past year, a smaller loss than the year before.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over MYSE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI has the edge over MYSE on profitability, with a higher operating margin.
MYSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $37 | -53% |
| Q1 2026 | $73 | -12% |
| Q4 2025 | $61 | -34% |
| Q3 2025 | $328 | +429% |
| Q2 2025 | $78 | -48% |
| Q1 2025 | $83 | -37% |
| Q4 2024 | $92 | -46% |
| Q3 2024 | $62 | -65% |
MYSE's revenue is growing: $37 last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5817057% | -4013431 points |
| Q1 2026 | -2308863% | -308326 points |
| Q4 2025 | -1872431% | -663521 points |
| Q3 2025 | -390427% | +1606644 points |
| Q2 2025 | -1803626% | -964485 points |
| Q1 2025 | -2000537% | -730752 points |
| Q4 2024 | -1208910% | -373353 points |
| Q3 2024 | -1997071% | -544413 points |
MYSE's operating margin was −5817057% last quarter, down 4013431 points from the same quarter a year ago, near the bottom of its range since 2022.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
MYSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.3M | +$154.3K |
| Q1 2025 | -$1.4M | +$71.9K |
| Q4 2023 | -$1.4M | +$161.4K |
| Q3 2023 | -$2M | +$55.6K |
| Q3 2022 | -$2.1M | -$704.1K |
| Q1 2022 | -$2.3M | -$1.6M |
| Q3 2021 | -$1.3M | -$1M |
| Q1 2021 | -$650.2K | -$379.7K |
MYSE has burned cash in almost every quarter: −$4M over the past year, against −$6M the year before.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
MYSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +699K shares |
| 1 year | +18% | +771K shares |
| 3 years | +142% | +2.9M shares |
| 5 years | +272% | +3.6M shares |
MYSE has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYSE Net Leverage
MYSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
MYSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 0.6 | Oversold |
MYSE's weekly RSI is 34 (neutral) and its Stochastic is 1 (oversold).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
MYSE PE vs Technology Sector
MYSE has no meaningful PE right now: it lost money over the past year.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has the edge over MYSE on trend strength, trading above more of its moving averages.
MYSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 29% below |
| 20 week MA | $2.11 | 50% below |
| 50 week MA | $2.05 | 48% below |
| 100 week MA | $2.31 | 54% below |
| 200 week MA | $2.59 | 59% below |
MYSE is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over MYSE on returns for 2026, with the stronger performance.
MYSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $33.9 | -0.9% |
| 2022 | $33.9 | $3.15 | -91% |
| 2023 | $3.15 | $2.87 | -8.9% |
| 2024 | $2.87 | $1.84 | -36% |
| 2025 | $1.84 | $1.87 | +1.6% |
| 2026 YTD | $1.87 | $1.06 | -43% |
MYSE has finished lower in four of the last five years. It's down 43% so far in 2026.